SAN DIEGO — Aithanh Nguyen is skipping school to attend the American Society of Hematology’s annual meeting, but she has a legit excuse: On Monday, Nguyen was slated to take the podium here to present her research findings about a potential new mechanism for pain in sickle cell disease. The research could one day lead to new drugs to treat the chronic pain that plagues patients with the inherited blood disorder.

The missed classes are at a Connecticut boarding school, where Nguyen is a senior. She’s 17 and the youngest scientist making a presentation at the ASH annual meeting.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Aithanh, we are so proud of you. May God continue opening your heart and mind to reach out to our suffering sisters and brothers.

  • If every young “genius” would achieve just a fraction of what they are flaunted will achieve, there will be no more disease, wars and famine in the world.

    BTW, didn’t Global Blood Therapeutics and Bluebird Bio just made her research outdated? ………… So, mean

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy